Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model

CD8+Foxp3+ T cells share developmental and phenotypic features with classical CD4+Foxp3+ regulatory T cells but lack potent suppressive activity

(2011) Christian T. Mayer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The History and Future of Chemotherapy for Melanoma

(2009) Arvin S. Yang et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases

(2009) Nicole Suciu-Foca et al.   HUMAN IMMUNOLOGY

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

(2008) S. Sauer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Biology of Interleukin-2

(2007) Thomas R. Malek   Annual Review of Immunology